Leverage your data to drive clinical outcomes
Accelerate innovation with real world data
Log in to the OMNY Health Platform
Learn more about OMNY Health
Join our rapidly growing team
Meet our team at upcoming events
Keep up with the latest news
Keep the conversation going
OMNY Health (OMNY Inc.) is pleased to announce it has partnered with the nation’s leading community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patters for AA within a diverse set of US healthcare settings. ILCS and TCS were by far the most common...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insight into characteristics and treatments of pediatric HS within a diverse set of US healthcare setting. Acne presented as the most common...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patterns for HS within a diverse set of US healthcare settings. Adalimumab use has increased steadily since the...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? We were unable to observe higher than 58% accuracy with our NLP model. Nevertheless, this analysis represents an important initial step in developing a more...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world trends in use of biologics for treatment of PsA. Patient use of biologics increased steadily over the observation period...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? These results suggest that T5 models are capable of extracting disease specific knowledge from clinical notes. Areas for further research include studying how...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insights into real-world treatment patterns for vitiligo within a diverse set of US healthcare settings. Increased use of TCS and TCI coincided...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? The BSA x PGA product shows promise as a single metric to measure DA inAD patients given the ability to predict STI. Given the complexity of collecting clinical...
On May 15 – May 18, 2022, this poster was on display at ISPOR 2022. What is the Objective of this Poster? Results provide insight into use of cosmetic procedures among patients in specialty dermatology networks in the United States Neurotoxin use increased, while...
By continuing to use the site, you agree to the use of cookies. More information.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below, then you are consenting to this.